ISC disease management series - Complicated and nosocomial urinary tract infections: Part II of the International Symposium Hot Topics in Urinary Tract Infection, January 25, 2003, Budapest, HungaryNABER, Kurt G; PECHERE, Jean-Claude; LUDWIG, Endre et al.International journal of antimicrobial agents. 2004, Vol 23, issn 0924-8579, 90 p., SUP1Conference Proceedings

Single-drug or combined antibacterial therapy in the treatment of patients with chronic prostatitis and Chlamydia trachomatis?SMELOV, V; GORELOV, A; SMELOVA, N et al.International journal of antimicrobial agents. 2004, Vol 23, pp S83-S87, issn 0924-8579, SUP1Conference Paper

Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infectionNABER, K. G; LANDEN, H.International journal of antimicrobial agents. 2004, Vol 23, pp S35-S40, issn 0924-8579, SUP1Conference Paper

Controversies in antibiotic prophylaxis in urologyGRABE, Magnus.International journal of antimicrobial agents. 2004, Vol 23, pp S17-S23, issn 0924-8579, SUP1Conference Paper

Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitisSMELOV, V; KRYLOVA, T; SMELOVA, N et al.International journal of antimicrobial agents. 2004, Vol 23, pp S79-S82, issn 0924-8579, SUP1Conference Paper

Emergence of antibiotic resistance and prudent use of antibiotic therapy in nosocomially acquired urinary tract infectionsWAGENLEHNER, F. M. E; NABER, K. G.International journal of antimicrobial agents. 2004, Vol 23, pp S24-S29, issn 0924-8579, SUP1Conference Paper

Nosocomially acquired urinary tract infections in urology departments. Why an international prevalence study is needed in urologyBJERKLUND JOHANSEN, Truls E.International journal of antimicrobial agents. 2004, Vol 23, pp S30-S34, issn 0924-8579, SUP1Conference Paper

Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infectionsTALAN, David A; NABER, Kurt G; PALOU, Juan et al.International journal of antimicrobial agents. 2004, Vol 23, pp S54-S66, issn 0924-8579, SUP1Conference Paper

Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheterSAMUEL, U; GUGGENBICHLER, J. P.International journal of antimicrobial agents. 2004, Vol 23, pp S75-S78, issn 0924-8579, SUP1Conference Paper

Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infectionsNABER, K. G; BARTNICKI, A; BISCHOFF, W et al.International journal of antimicrobial agents. 2004, Vol 23, pp S41-S53, issn 0924-8579, SUP1Conference Paper

Bacterial biofilm formation on urologic devices and heparin coating as preventive strategyTENKE, Peter; RIEDL, Claus R; JONES, Gwennan Ll et al.International journal of antimicrobial agents. 2004, Vol 23, pp S67-S74, issn 0924-8579, SUP1Conference Paper

Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral doseBOY, Dieter; WELL, Michaela; KINZIG-SCHIPPERS, Martina et al.International journal of antimicrobial agents. 2004, Vol 23, pp S6-S16, issn 0924-8579, SUP1Conference Paper

Etiology and susceptibility of urinary tract isolates in KosovaRAKA, Lul; MULLIQI-OSMANI, Gjyle; BERISHA, Lule et al.International journal of antimicrobial agents. 2004, Vol 23, pp S2-S5, issn 0924-8579, SUP1Conference Paper